Algalíf is a commercial producer of natural products derived from microalgae. The company was founded in 2012, but began formal operations in Iceland in October 2013. The company currently has 35 full-time employees on-site.
The company is a part of Sana Pharma Holding, an international company founded in 2002 with businesses in ingredient manufacturing, food supplements, medical devices and over-the-counter medicines. Sana Pharma is established in Norway, Sweden, Denmark, Finland, Iceland, the Czech Republic and the United States, with more than 200 employees.
Being located in Iceland offers significant advantages especially in terms of water availability and purity, air quality, access to renewable energy and overall sustainability aspects. This ties together with Algalíf’s emphasis on quality and contamination control, two key aspects of algae cultivation and development of products from natural ingredients.
Algalíf is dedicated to solving the nutritional needs of current and future generations and currently produces high-quality astaxanthin, through cultivation of the microalgae Haematococcus pluvialis. Astalíf™ astaxanthin was the first step in creating microalgae-derived products using an in-house designed tubular photobioreactor (PBR) cultivation system, powered by a proprietary LED lighting system. By using this production method, Algalíf has set new industry benchmarks for astaxanthin production and surpassed industry-accepted maxima of astaxanthin content in algae biomass, as well as the overall process productivity.
